WOCN Homepage


207

Achieving Maximum Performance with Calcium Alginate/CMC with Silver Dressing

Linda Galvan, RN, BSN, CWOCN, APN1, Chris Barkauskas, RN, BA, CWOCN, APN1, and Andrea McIntosh, RN, BSN, CWOCN, APN2. (1) Silver Cross Hospital, Wound Ostomy Continence Nurse, 1200 Maple Road, Joliet, IL 60432, (2) Silver Cross Hospital, Manager, Wound Center & WOCN Dept., 1200 Maple Road, Joliet, IL 60432

ACHIEVING MAXIMUM PERFORMANCE WITH CALCIUM ALGINATE/CMC WITH SILVER DRESSING*

PURPOSE: The purpose of this poster is to assess the performance of calcium alginate/carboxymethlycellulose (CMC) with silver dressing* for the treatment of chronic wounds that are colonized or at high risk for infection.

OBJECTIVE: Due to the influx of multiple silver dressings on the market, it is essential to evaluate the performance characteristics of these products. The performance characteristics evaluated for the calcium alginate/CMC with silver dressing* were: absorption, wear time, ease of application and removal, and wound healing outcomes.

Calcium alginate/CMC with silver dressing* is a highly absorptive non- woven pad composed of calcium alginate, CMC and ionic silver. The ionic silver component releases Silver ions in the presence of wound exudate over a period of up to 4 days.

OUTCOMES: Results indicated the performance characteristics that were evaluated exceeded our criteria. The calcium alginate/CMC with silver dressing* is an effective bacterial barrier, highly absorptive and easy to apply and remove. Wear time ranged from 1 – 4 days dependent on wound type and amount of exudate. Excellent wound healing outcomes were achieved. The positive results assure us that we should continue to use the calcium alginate/CMC with silver dressing* in our facility.

FINANCIAL ASSISTANCE/DISCLOSURE: Poster is sponsored and funded by Medline Industries, Inc.

REFERENCES: 1. Baranoski S and Ayello EA Wound Care Essentials: Practice Principles. Baranoski, S and Ayello EA, Lippincott, 2003. 2. Ovington L. “Bacterial toxins and wound healing” Ostomy Wound Management, 2003; 49 (7A Suppl): 8-12.

* Maxorb Extra Ag, Medline Industries, Inc. Mundelein, Illinois.


See more of Practice Innovation Poster Abstracts
See more of Practice Innovation Abstracts

See more of The 38th Annual WOCN Society Conference (June 24 -- 28, 2006)